Trade

with

St Jude Medical Inc
(NYSE: STJ)
AdChoices
60.47
+0.45
+0.75%
After Hours :
60.47
0.00
0.00%

Open

60.23

Previous Close

60.02

Volume (Avg)

1.39M (1.67M)

Day's Range

59.82-60.48

52Wk Range

54.80-71.90

Market Cap.

17.22B

Dividend Rate (Yield )

- (1.75%)

Beta

1.35

Shares Outstanding

284.69M

P/E Ratio (EPS)

19.49 (3.10)

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
1.05B
Operating Margin
19.11
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
Ownership

Institutional Ownership

87.84%

Top 10 Institutions

39.53%

Mutual Fund Ownership

49.48%

Float

86.64%

5% / Insider Ownership

2.51%

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • VA CollegeAmerica Growth Fund of America

  •  

    9,915,000

  • 0.00

  • 3.48

  • VA CollegeAmerica Cap World Gr and Inc

  •  

    8,644,800

  • 0.68

  • 3.04

  • VA CollegeAmerica AMCAP

  •  

    6,766,465

  • 0.00

  • 2.38

  • Vanguard Total Stock Mkt Idx

  •  

    4,634,802

  • 0.43

  • 1.63

  • Vanguard Health Care Fund

  •  

    4,301,100

  • -26.41

  • 1.51

  • MFS® Value Fund

  •  

    3,737,585

  • 0.00

  • 1.31

  • Vanguard Five Hundred Index Fund

  •  

    2,955,642

  • 0.40

  • 1.04

  • Vanguard Institutional Index Fund

  •  

    2,883,989

  • -0.91

  • 1.01

  • SPDR® S&P 500 ETF

  •  

    2,824,088

  • 1.44

  • 0.99

  • Fidelity® Low-Priced Stock Fund

  •  

    2,389,600

  • -0.43

  • 0.84

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • Capital Research Global Investors

  •  

    29,909,171

  • +24.35%

  • 10.51

  • MFS Investment Management K.K.

  •  

    20,230,697

  • -0.66%

  • 7.11

  • Vanguard Group, Inc.

  •  

    14,009,926

  • +2.02%

  • 4.92

  • State Street Corp

  •  

    12,255,236

  • +0.26%

  • 4.31

  • BlackRock Fund Advisors

  •  

    9,577,499

  • -6.28%

  • 3.37

  • Wellington Management Company, LLP

  •  

    7,769,948

  • -7.44%

  • 2.73

  • Fidelity Management and Research Company

  •  

    6,654,836

  • -3.98%

  • 2.34

  • Sanders Capital, LLC

  •  

    4,411,820

  • +1.71%

  • 1.50

  • Lord, Abbett & Co LLC

  •  

    3,922,045

  • +40.78%

  • 1.38

  • Northern Trust Investments, N.A.

  •  

    3,876,404

  • -8.25%

  • 1.36

Company Profile

Sector

Healthcare

Industry

Medical Devices

Type

Slow Growth

Style

Large Core

St Jude Medical, Inc., was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and...more neurostimulation medical devices for the management of chronic pain. The Company’s two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company’s principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) – tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) – ...morevascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company’s commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an external clinician programmer that is used to program the implant with individualized therapy for the patient. ICDs and cardiac resynchronization therapy defibrillator (CRT-D) devices treat patients with hearts that beat inappropriately fast, a condition known as tachycardia. ICDs monitor the heartbeat and deliver high energy electrical impulses, or “shocks,” to treat potentially lethal, abnormally fast heart rhythms (ventricular tachycardia (VT) and ventricular fibrillation (VF)), which often lead to sudden cardiac death (SCD). The Company competes against two principal tissue heart valve manufacturers – Edwards Lifesciences Corporation (Edwards Lifesciences) and Medtronic – as well as many other smaller manufacturers.lessless

Key People

Daniel J. Starks

CEO/Chairman of the Board/Director/President

Donald J. Zurbay

CFO/Chief Accounting Officer/Vice President, Divisional

Mark W. Murphy

Chief Information Officer/Vice President, Divisional

Thomas R. Northenscold

Vice President, Divisional/Chief Information Officer

John C. Heinmiller

Executive VP

Incorporated

1976

Employees

-

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: